Abbott (ABT) is close to announcing a deal to buy Belgian conglomerate Solvay's (SVYSY.PK) drug...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Abbott (ABT) is close to announcing a deal to buy Belgian conglomerate Solvay's (SVYSY.PK) drug unit for about $7.6B in cash. A deal could be announced as early as Monday. Abbott and Solvay already sell two drugs for cholesterol and triglycerides together; a deal would give Abbott access to Solvay's drugs for hypertension and Parkinson's disease. (WSJ)